Published in Virology on February 01, 1977
Herpesvirus glycoprotein synthesis and insertion into plasma membranes. J Virol (1982) 1.61
Effect of cytochalasin B on the maturation of enveloped viruses. J Exp Med (1979) 1.28
Polypeptide synthesized in herpes simplex virus type 2-infected HEp-2 cells. Virology (1975) 5.47
A virion-associated glycoprotein essential for infectivity of herpes simplex virus type 1. Virology (1981) 4.37
Isolation and characterization of a large molecular-weight polypeptide of herpes simplex virus type 1. Virology (1974) 3.32
Preparation and characterization of specific antisera to individual glycoprotein antigens comprising the major glycoprotein region of herpes simplex virus type 1. J Virol (1980) 2.92
Synthesis of virus-specific polypaptides by temperature-sensitive mutants of herpes simplex virus type 1. Virology (1976) 2.72
gA and gB glycoproteins of herpes simplex virus type 1: two forms of a single polypeptide. J Virol (1980) 2.63
Immunological and biochemical characterization of polypeptides induced by herpes simplex virus types 1 and 2. IARC Sci Publ (1975) 2.59
Use of monoclonal antibody directed against herpes simplex virus glycoproteins to protect mice against acute virus-induced neurological disease. Infect Immun (1981) 2.49
Comparative neurovirulence of herpes simplex virus type 1 strains after peripheral or intracerebral inoculation of BALB/c mice. Infect Immun (1983) 2.21
A temperature-sensitive mutant of herpes simplex virus type 1 defective in the synthesis of the major capsid polypeptide. J Gen Virol (1974) 2.16
Characterization of the large tegument protein (ICP1/2) of herpes simplex virus type 1. Virology (1992) 2.14
Endo-beta-N-acetylglucosaminidase H sensitivity of precursors to herpes simplex virus type 1 glycoproteins gB and gC. J Virol (1982) 2.13
Biology of Naegleria spp. Microbiol Rev (1988) 2.06
Effects of 2-deoxy-D-glucose on herpes simplex virus replication. Virology (1973) 2.00
Virus-specific glycoproteins associated with the nuclear fraction of herpes simplex virus type 1-infected cells. J Virol (1984) 1.96
The synthesis of herpes simplex virus proteins in the absence of virus DNA synthesis. Biochem Biophys Res Commun (1975) 1.95
Identification and characterization of the herpes simplex virus type 1 virion protein encoded by the UL35 open reading frame. J Virol (1992) 1.91
Intracellular trafficking of the UL11 tegument protein of herpes simplex virus type 1. J Virol (2001) 1.90
Cell-mediated immunity against herpes simplex induction of cytotoxic T lymphocytes. Infect Immun (1980) 1.85
The increasing importance of Acanthamoeba infections. J Eukaryot Microbiol (2000) 1.78
Association of ICP0 but not ICP27 with purified virions of herpes simplex virus type 1. J Virol (1992) 1.76
Detection of an immediate early herpes simplex virus type 1 polypeptide in trigeminal ganglia from latently infected animals. Infect Immun (1981) 1.72
Cell-mediated immunity to herpes simplex virus: specificity of cytotoxic T cells. Infect Immun (1980) 1.71
Temperature-sensitive mutants of herpes simplex virus type 1 defective in transcriptional and post-transcriptional functions required for viral DNA synthesis. Virology (1978) 1.70
CB2 receptors in the brain: role in central immune function. Br J Pharmacol (2007) 1.66
Chemical cross-linking of virion envelope and tegument proteins of herpes simplex virus type 1. Virology (1994) 1.64
Direction of transneuronal transport of herpes simplex virus 1 in the primate motor system is strain-dependent. Proc Natl Acad Sci U S A (1991) 1.58
A major transcriptional regulatory protein (ICP4) of herpes simplex virus type 1 is associated with purified virions. J Virol (1989) 1.55
Antigens specified by herpesviruses. II. Effect of arginine deprivation on the synthesis of cytoplasmic and nuclear proteins. Virology (1971) 1.50
Comparative analysis of polypeptides induced by type 1 and type 2 strains of herpes simplex virus. Intervirology (1977) 1.48
Viral gene functions expressed and detected by temperature-sensitive mutants of herpes simplex virus. Cold Spring Harb Symp Quant Biol (1975) 1.48
Posttranslational modification and subcellular localization of the p12 capsid protein of herpes simplex virus type 1. J Virol (1992) 1.45
Differential expression of the CB2 cannabinoid receptor by rodent macrophages and macrophage-like cells in relation to cell activation. Int Immunopharmacol (2002) 1.44
Thymidine kinase activity of herpes simplex virus temperature-sensitive mutants. Intervirology (1973) 1.42
Processing of the herpes simplex virus type 2 glycoprotein gG-2 results in secretion of a 34,000-Mr cleavage product. J Virol (1987) 1.42
Analysis of the UL36 open reading frame encoding the large tegument protein (ICP1/2) of herpes simplex virus type 1. J Virol (1992) 1.42
Assay of type-specific and type-common antibodies to herpes simplex virus types 1 and 2 in human sera. Infect Immun (1981) 1.41
Cyclic appearance of defective interfering particles of herpes simplex virus and the concomitant accumulation of early polypeptide VP175. Intervirology (1975) 1.40
The central cannabinoid receptor (CB1) mediates inhibition of nitric oxide production by rat microglial cells. J Pharmacol Exp Ther (1999) 1.38
Herpes simplex virus type 1-specific cytotoxic T lymphocytes recognize virus nonstructural proteins. J Virol (1988) 1.37
Cellular and humoral immunity in guinea pigs to two major polypeptides derived from hepatitis B surface antigen. J Gen Virol (1978) 1.37
A temperature-sensitive mutant of herpes simplex virus defective in glycoprotein synthesis. Virology (1971) 1.36
Membrane targeting properties of a herpesvirus tegument protein-retrovirus Gag chimera. J Virol (2000) 1.36
Expression of an early, nonstructural antigen of herpes simplex virus in cell transformed in vitro by herpes simplex virus. J Virol (1977) 1.33
Structural proteins of Pichinde virus. J Virol (1972) 1.33
Cannabinoids inhibit LPS-inducible cytokine mRNA expression in rat microglial cells. Glia (2000) 1.30
DNA-negative temperature-sensitive mutants of herpes simplex virus type 1: patterns of viral DNA synthesis after temperature shift-up. J Virol (1976) 1.29
Cytomegalovirus and herpes simplex virus ascending myelitis in a patient with acquired immune deficiency syndrome. Ann Neurol (1985) 1.25
Herpesvirus-induced antigens in squamous-cell carcinoma in situ of the vulva. N Engl J Med (1981) 1.25
In vitro destruction of nerve cell cultures by Acanthamoeba spp.: a transmission and scanning electron microscopy study. J Parasitol (1996) 1.25
Immunohistochemical localization of the neural cannabinoid receptor in rat brain. J Neurosci Res (1998) 1.22
Cannabinoid receptors in microglia of the central nervous system: immune functional relevance. J Leukoc Biol (2005) 1.21
Multimeric forms of herpes simplex virus type 2 glycoproteins. J Virol (1982) 1.20
Infection and replication of herpes simplex virus type 1 in an organotypic epithelial culture system. Virology (1997) 1.16
Detection of herpesvirus type-specific antibody by a micro solid phase radioimmunometric assay. Intervirology (1979) 1.14
Cannabinoid inhibition of the processing of intact lysozyme by macrophages: evidence for CB2 receptor participation. J Pharmacol Exp Ther (1999) 1.12
Production of antibody to individual polypeptides derived from purified hepatitis B surface antigen. J Virol (1975) 1.12
Studies on herpes simplex virus and cancer. Cancer Res (1976) 1.12
Herpes simplex virus glycoproteins: isolation of mutants resistant to immune cytolysis. J Virol (1980) 1.11
Herpes simplex virus protein synthesis in the presence of 2-deoxy-D-glucose. Virology (1976) 1.11
Murine cytotoxic T lymphocytes specific for herpes simplex virus type 1 recognize the immediate early protein ICP4 but not ICP0. J Gen Virol (1990) 1.10
Recurrent herpes simplex encephalitis: recovery of virus after Ara-A treatment. Ann Neurol (1983) 1.08
Herpes simplex virus type 1. A cause of the acute retinal necrosis syndrome. Ophthalmology (1989) 1.08
Glycosylation of herpes simplex virus type 1 gC in the presence of tunicamycin. J Virol (1983) 1.06
Antigens specified by herpesviruses. I. Effect of arginine deprivation on antigen synthesis. Virology (1970) 1.04
Comparison of Naegleria fowleri and Naegleria gruberi cultivated in the same nutrient medium. J Protozool (1983) 1.04
Cytopathogenicity of Naegleria fowleri for rat neuroblastoma cell cultures: scanning electron microscopy study. Infect Immun (1983) 1.03
Agglutination of Naegleria fowleri and Naegleria gruberi by antibodies in human serum. J Clin Microbiol (1983) 1.00
A dominant lethal temperature-sensitive mutant of herpes simplex virus type 1. Virology (1981) 0.99
Herpetic proctitis and meningitis: recovery of two strains of herpes simplex virus type 1 from cerebrospinal fluid. J Infect Dis (1982) 0.99
Ultrastructural characterization of an early, nonstructural polypeptide of herpes simplex virus type 1. J Virol (1980) 0.99
Role of a conserved lysine residue in the peripheral cannabinoid receptor (CB2): evidence for subtype specificity. Mol Pharmacol (1999) 0.99
Delivery of ultraviolet-inactivated 35S-herpesvirus across an osmotically modified blood-brain barrier. J Neurosurg (1991) 0.98
Movement of Naegleria fowleri stimulated by mammalian cells in vitro. J Protozool (1986) 0.98
Specificity of antibodies from human sera for Naegleria species. J Clin Microbiol (1987) 0.98
Electron microscope studies of temperature-sensitive mutants of herpes simplex virus type 2. J Virol (1976) 0.97
Cytolytic activity of Naegleria fowleri cell-free extract. J Protozool (1986) 0.97
Acute and latent herpes simplex virus neurological disease in mice immunized with purified virus-specific glycoproteins gB or gD. J Med Virol (1985) 0.96
Inducible expression of herpes simplex virus type 2 glycoprotein gene gG-2 in a mammalian cell line. J Virol (1988) 0.96
Antibody to herpes simplex virus type 2-induced nonstructural proteins in women with cervical cancer and in control groups. J Natl Cancer Inst (1975) 0.95
Viability of herpes simplex virus type 1 on the applanation tonometer. Am J Ophthalmol (1987) 0.94
Effects of cytochalasin B on herpes simplex virus type 1 replication. Virology (1976) 0.94
Orientation of the cleavage site of the herpes simplex virus glycoprotein G-2. J Virol (1993) 0.93
In vitro synthesis and processing of herpes simplex virus type 2 gG-2, using cell-free transcription and translation systems. J Virol (1990) 0.93
Staining characteristics and antiviral activity of sulforhodamine B and lissamine green B. Invest Ophthalmol Vis Sci (1994) 0.93
Resistance of Acanthamoeba species to complement lysis. J Parasitol (1998) 0.92
Association of a major transcriptional regulatory protein, ICP4, of herpes simplex virus type 1 with the plasma membrane of virus-infected cells. J Virol (1991) 0.92
Anandamide inhibits macrophage-mediated killing of tumor necrosis factor-sensitive cells. Life Sci (1995) 0.92
Amplification of two endo R-Hind III-restricted fragments of the DNA of herpes simplex virus type 1. Virology (1978) 0.92
Evidence for post-translational glycosylation of a nonglycosylated precursor protein of herpes simplex virus type 1. J Virol (1984) 0.91
Incorporation of 2-deoxy-D-glucose into glucoproteins of normal and Simian virus 40-transformed hamster cells. Cancer Res (1973) 0.91
Susceptibility of pathogenic and nonpathogenic Naegleria spp. to complement-mediated lysis. Infect Immun (1987) 0.90
Immunologic and biochemical characterization of individual polypeptides induced by herpes simplex virus types 1 and 2. Adv Pathobiol (1976) 0.90
delta 9-Tetrahydrocannabinol modulates antigen processing by macrophages. J Pharmacol Exp Ther (1995) 0.90